title: Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics.
abstract: Limbic cortical regions, including anterior cingulate cortex (ACC), prefrontal cortex (PFC) and entorhinal cortex (ERC), have been implicated in the neuropathology of schizophrenia. Glutamate projection neurons connect these limbic cortical regions to each other, as well as to the terminal fields of the striatal/accumbens dopamine neurons. Subsets of these glutamate projection neurons, and of the GABA interneurons in cortex, contain the neuropeptide cholecystokinin (CCK). In an effort to study the limbic cortical glutamate projection neurons and GABA interneurons in schizophrenia, we have measured CCK mRNA with in situ hybridization histochemistry in postmortem samples of dorsolateral (DL)PFC, ACC and ERC of seven schizophrenics, nine non-psychotic suicides and seven normal controls. CCK mRNA is decreased in ERC (especially layers iii vi) and subiculum in schizophrenics relative to controls. Cellular analysis indicates that there is a decrease in density of CCK mRNA in labelled neurons. In so far as ERC CCK mRNA is not reduced in rats treated chronically with haloperidol, this decrease in schizophrenics does not appear to be related to neuroleptic treatment. In contrast, in DLPFC, where schizophrenics do not differ from normals, the suicide victims have elevated CCK mRNA (especially in layers v and vi), and increased cellular density of CCK mRNA, relative to both normals and schizophrenics. These results lend further support for the involvement of ERC and hippocampus in schizophrenia, suggesting that neurons that utilize CCK may be particularly important. Similarly, an increase in CCK mRNA levels in the PFC of suicides adds to a growing body of evidence implicating this structure in this pathological state. In so far as CCK is co-localized with GABA or glutamate in cortical neurons, both of these neuronal populations need to be studied further in schizophrenia and suicide.
authors.affiliation: Clinical Brain Disorders Branch, IRP/NIMH/NIH, Neuroscience Center at St. Elizabeths Hospital, Washington, DC 20032, USA. BACHUSS@dirpc.nimh.nih.gov
authors.forename: S E
authors.initials: SE
authors.lastname: Bachus
authors.forename: T M
authors.initials: TM
authors.lastname: Hyde
authors.forename: M M
authors.initials: MM
authors.lastname: Herman
authors.forename: M F
authors.initials: MF
authors.lastname: Egan
authors.forename: J E
authors.initials: JE
authors.lastname: Kleinman
mesh_terms: D000818:Animals; D001931:Brain Mapping; D002766:Cholecystokinin / Q000235:genetics*; D018728:Entorhinal Cortex / Q000473:pathology*; D015870:Gene Expression / Q000502:physiology; D006179:Gyrus Cinguli / Q000473:pathology; D006801:Humans; D017403:In Situ Hybridization; D008297:Male; D000090204:Mesothelin; D017397:Prefrontal Cortex / Q000473:pathology; D012333:RNA, Messenger / Q000235:genetics*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012016:Reference Values; D012559:Schizophrenia / Q000235:genetics* / Q000473:pathology; D012565:Schizophrenic Psychology
chemical_list: C000715529:Msln protein, rat; D012333:RNA, Messenger; D002766:Cholecystokinin; D000090204:Mesothelin